Home/News & Press/Wondfo News/Wondfo Biotech | ISTH 2024 Leading Thrombosis and Hemostasis Diagnostic Solution
Wondfo Biotech | ISTH 2024 Leading Thrombosis and Hemostasis Diagnostic Solution
July 03,2024 (Edit) Wondfo
The 32nd International Congress on Thrombosis and Haemostasis (ISTH) was held from 22-26 June 2024 in Bangkok, Thailand. As one of the high-level international academic events in the field of thrombosis and haemostasis, ISTH Congress hosted a series of presentations and symposia, covering a wide range of topics from basic research to clinical applications. More than 5,000 medical researchers, clinicians, and industry leaders from all over the world shared the latest research results, exchanged cutting-edge scientific discoveries, and explored ways to bring comprehensive preventive strategies for patients with thrombosis and bleeding disorders around the globe.

Wondfo's Breakthroughs in Coagulation Testing
As the only Chinese brand in the IVD industry in the congress, Wondfo demonstrated our strength in the field of coagulation testing, and gained the recognition from many experts and scholars for its new chemiluminescence platform-Smarlumi™ FC-2100, and the leading screening items for early thrombosis in China, the 4-Item Test: TAT, TM, PIC, and t-PAIC.

New Thrombosis Testing, Wondfo Solution Gains Recognition
"I haven't learned about these indicators before, and the current mainstream test is still based on D-Dimer." The hematologist from Berlin, Germany showed great interest in Wondfo's Thrombosis 4-Item Test (TAT, TM, PIC, t-PAIC) and hoped to explore how these new indicators helps assist diagnosis and treatment. Compared with traditional coagulation tests, thrombus markers can reflect the hypercoagulable state of the body at an earlier stage and provide early warning of thrombotic diseases. In 2020, Wondfo launched the Thrombus 4-Item Test, becoming the first product capable of simultaneously testing six thrombotic markers from a single blood sample using a single instrument, leading domestic industry.

One of the Saudi Arabia pediatricians showed great enthusiasm for Wondfo's coagulation testing solution. He noted that traditional laboratory tests can take hours to days to produce results. Fast results are significant for pediatric patients who need quick diagnostic decisions, such as in ER. In addition to praising Wondfo's Coagulation 4 Test Items (PT, APTT, FIB, TT) and ACT, he was also impressed by Immunofluorescence platform, pointing out that D-Dimer for POCT will help save a lot of time.

Racing for life, Wondfo will continue to drive high-quality development through scientific research innovation, striving to make biotechnology benefit all.
This website uses cookies. By continuing to browse or by clicking “Accept”, you agree to our use of cookies to enhance your experience.

Choose your location

It looks like you are located in: Spain
You are trying to view a page from a different country or region. *Not all products and services may be available in your country or region.